FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine. Disclosed is the use of pCMV-VEGF plasmid splicing version 165 (Seq # 1) for treating diabetic foot syndrome and method for treating diabetic foot syndrome.
EFFECT: presented group of inventions provides improved treatment results for diabetic foot by means of gene therapy.
3 cl, 3 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SOFT TISSUES DEFECTS TREATMENT IN PATIENTS WITH DIABETIC FOOT SYNDROME | 2016 |
|
RU2619257C1 |
| METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
| METHOD FOR TREATING DIABETIC FOOT SYNDROME BEFORE FORMATION OF ULCEROUS DEFECT USING EXTRACORPORAL SHOCK WAVE THERAPY | 2016 |
|
RU2632683C1 |
| METHOD FOR TREATMENT OF UNINFECTED POSTOPERATIVE WOUND DEFECT OF THE FOOT IN THE ABSENCE OF SIGNS OF CRITICAL LIMB ISCHEMIA IN PATIENTS WITH NEUROPATHIC AND NEUROISCHEMIC FORMS OF DIABETIC FOOT SYNDROME | 2020 |
|
RU2754383C1 |
| METHOD OF TREATING NEUROPATHIC TROPHIC ULCERS ACCOMPANYING DIABETIC FOOT | 2013 |
|
RU2549459C2 |
| METHOD FOR DETERMINING PROGNOSIS OF WOUND DEFECT HEALING IN DIABETIC FOOT SYNDROME | 2020 |
|
RU2742760C1 |
| METHOD FOR PERSONALISING THERAPY OF AN ULCEROUS DEFECT IN DIABETIC FOOT SYNDROME | 2021 |
|
RU2785531C1 |
| METHOD FOR TREATING NEUROISCHEMIC DIABETIC FOOT SYNDROME | 2020 |
|
RU2754415C1 |
| METHOD FOR SELECTING SURGICAL TACTICS WHEN TREATING THE CASES OF DIABETIC FOOT SYNDROME | 2005 |
|
RU2299700C1 |
| MEDICINAL PRODUCT FOR THE TREATMENT OF ULCER DEFECTS IN "DIABETIC FOOT" SYNDROME | 2023 |
|
RU2804781C1 |
